These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6871470)

  • 1. Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia.
    Gmür J; von Felten A; Osterwalder B; Honegger H; Hörmann A; Sauter C; Deubelbeiss K; Berchtold W; Metaxas M; Scali G; Frick PG
    Blood; 1983 Aug; 62(2):473-9. PubMed ID: 6871470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ineffectiveness of random donor platelet transfusion in splenectomized, alloimmunized recipients.
    Hogge DE; Dutcher JP; Aisner J; Schiffer CA
    Blood; 1984 Jul; 64(1):253-6. PubMed ID: 6733276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed alloimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia.
    Sintnicolaas K; Vriesendorp HM; Sizoo W; Stenfert Kroese WF; Haije WG; Hop WC; Abels J; Löwenberg B
    Lancet; 1981 Apr; 1(8223):750-4. PubMed ID: 6110956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloimmunization following platelet transfusion: the absence of a dose-response relationship.
    Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
    Blood; 1981 Mar; 57(3):395-8. PubMed ID: 7459428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
    Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
    Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Refractory effect and alloimmunization after transfusion of thrombocytes].
    Volkova RI; Agranenko VA
    Gematol Transfuziol; 1992 Feb; 37(2):16-21. PubMed ID: 1426903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of platelet transfusions.
    Murphy MF; Waters AH
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine platelet alloimmunization: the role of donor selection.
    Slichter SJ; O'Donnell MR; Weiden PL; Storb R; Schroeder ML
    Br J Haematol; 1986 Aug; 63(4):713-27. PubMed ID: 3730294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
    Sintnicolaas K; van Marwijk Kooij M; van Prooijen HC; van Dijk BA; van Putten WL; Claas FH; Novotny VM; Brand A
    Blood; 1995 Feb; 85(3):824-8. PubMed ID: 7833483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions.
    Brand A; Claas FH; Voogt PJ; Wasser MN; Eernisse JG
    Vox Sang; 1988; 54(3):160-6. PubMed ID: 3369136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations.
    Daly PA; Schiffer CA; Aisner J; Wiernik PH
    JAMA; 1980 Feb; 243(5):435-8. PubMed ID: 7351763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets.
    O'Rafferty C; Rooney G; Hagan R; Woolfson M; O'Donghaile D; Fitzgerald J
    Transfus Med; 2017 Oct; 27 Suppl 5():369-374. PubMed ID: 28393455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion.
    Hogge DE; Dutcher JP; Aisner J; Schiffer CA
    Am J Hematol; 1983 Jun; 14(4):363-9. PubMed ID: 6859034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience.
    Karlström C; Linjama T; Edgren G; Lauronen J; Wikman A; Höglund P
    Transfusion; 2019 Mar; 59(3):945-952. PubMed ID: 30575964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates.
    McFarland JG; Anderson AJ; Slichter SJ
    Br J Haematol; 1989 Nov; 73(3):380-6. PubMed ID: 2605125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
    Lee EJ; Schiffer CA
    Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
    van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
    Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.